Intraoral Scanner Assessment of Maxillary Marginal Soft Tissue Volume Change After Non-Surgical Periodontal Therapy in Type 2 Diabetes
Evaluation of Marginal Soft Tissue Volume Changes in the Maxilla After Non-Surgical Periodontal Therapy Using an Intraoral Scanner and Their Relationship With Type 2 Diabetes Mellitus: A Prospective Observational Cohort Study
Gum treatment (non-surgical periodontal therapy, also called scaling and root planing) reduces swelling in the gums. As the swelling goes down, the gum tissue around the teeth can shrink. This change is hard to measure with routine dental examinations. This study uses a 3D intraoral scanner, which takes digital images of the mouth without X-rays, to measure how much the gum tissue of the upper jaw changes in volume after treatment.
The study also asks whether this change is different in people with type 2 diabetes compared with people without diabetes. Diabetes can slow healing and change the body's inflammatory response, but its effect on gum volume after periodontal treatment has not been measured in three dimensions before.
Adults with stage III periodontitis who attend the Periodontology clinic at Afyonkarahisar Health Sciences University, Faculty of Dentistry, are invited to take part. Participants receive their routine gum treatment, which is not changed because of the study. Their upper jaw is scanned with an intraoral scanner before treatment and again at the routine 3-month check-up. The two scans are overlaid on a computer, and the change in gum volume is calculated. Researchers then compare people with and without type 2 diabetes.
Diabetes status and HbA1c values are taken from existing health records. The study does not require extra blood tests, X-rays, or extra visits.
Studieoversigt
Status
Status
Betingelser
Betingelser
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Adults with generalized stage III periodontitis attending the Periodontology clinic of Afyonkarahisar Health Sciences University, Faculty of Dentistry, who need routine non-surgical periodontal therapy. Participants are classified by existing health records as having type 2 diabetes or being systemically healthy.
Beskrivelse
Inclusion Criteria:
Adults aged 18 years or older who provide written informed consent
- Generalized stage III periodontitis (2017 World Workshop classification)
- All maxillary teeth present (third molars excluded)
- Tooth mobility of Miller grade 0 or 1
- Type 2 diabetes group: type 2 diabetes mellitus diagnosis confirmed from existing health records
- Non-diabetic group: systemically healthy, with an existing HbA1c below 5.7%
Exclusion Criteria:
- Stage IV periodontitis
- Any tooth with Miller mobility grade 2 or 3 in the study area
- Current smoking or heavy past smoking (10 pack-years or more)
- Periodontal treatment or antibiotic use within the previous 6 months
- Pregnancy or lactation
- Medication causing gingival enlargement (e.g., phenytoin, cyclosporine, calcium channel blockers) or immunosuppressive therapy
- Systemic disease other than diabetes that affects the periodontium
- Extensive restorations, fixed prostheses, or implants in the maxillary teeth
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Antal grupper/kohorter
Kohorter og interventioner
Gruppe / kohorteGruppe / kohorte |
|---|
|
Type 2 Diabetes With Stage III Periodontitis
Adults with type 2 diabetes mellitus (diagnosis confirmed from existing health records) and generalized stage III periodontitis who receive routine non-surgical periodontal therapy at the Periodontology clinic. The treatment is not altered for the study. The upper jaw is scanned with an intraoral scanner before treatment and at the routine 3-month check-up. |
|
No Diabetes With Stage III Periodontitis
Systemically healthy adults without diabetes (confirmed from existing health records) with generalized stage III periodontitis who receive routine non-surgical periodontal therapy at the Periodontology clinic. The treatment is not altered for the study. The upper jaw is scanned with an intraoral scanner before treatment and at the routine 3-month check-up. |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Buccal Marginal Gingival Soft Tissue Volume of the Maxilla
Tidsramme: Baseline (before treatment) to 3 months after non-surgical periodontal therapy
|
Volume change (mm3) of the buccal marginal gingival tissue of the maxillary arch, measured on superimposed 3D intraoral scans. Scans are overlaid on the tooth crown surfaces and the volume between baseline and 3-month surfaces is calculated within a region of interest bounded coronally by the gingival margin and apically by the mucogingival junction. |
Baseline (before treatment) to 3 months after non-surgical periodontal therapy
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- Decision No. 2026/605
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .